Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.
- DOI
- 10.1016/j.jdiacomp.2026.109397
- Published
- 2026 Oct
- Container
- Journal of diabetes and its complications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jdiacomp.2026.109397,
title = {Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.},
author = {Gullaksen S and Vernstrøm L and Sørensen SS and Funck KL and Poulsen PL and Laugesen E},
year = {2026},
journal = {Journal of diabetes and its complications},
doi = {10.1016/j.jdiacomp.2026.109397},
url = {https://doi.org/10.1016/j.jdiacomp.2026.109397}
}RIS
TY - JOUR TI - Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial. AU - Gullaksen S AU - Vernstrøm L AU - Sørensen SS AU - Funck KL AU - Poulsen PL AU - Laugesen E PY - 2026 JO - Journal of diabetes and its complications DO - 10.1016/j.jdiacomp.2026.109397 UR - https://doi.org/10.1016/j.jdiacomp.2026.109397 ER -
APA
S, G., L, V., SS, S., KL, F., PL, P., & E, L. (2026). Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.. Journal of diabetes and its complications. https://doi.org/10.1016/j.jdiacomp.2026.109397
Source records
- pubmed · retrieved 2026-09-26T12:03:06.450Z